Health · 9 views

FDA approves once-daily Idvynso tablet for treating HIV

The U.S. Food and Drug Administration has approved Merck's Idvynso (doravirine/islatravir), a new, once-daily, two-drug single tablet for…

Source Medical Xpress AI Summary Updated May 2, 2026

Story intelligence Beta

Freshness Stale Updated May 2, 2026

Confidence Limited Single-outlet story

Coverage Single outlet

Views 9 Community interest

Read time 1 min ~39 words

AI Summary

The U.S. Food and Drug Administration has approved Merck's Idvynso (doravirine/islatravir), a new, once-daily, two-drug single tablet for the treatment of HIV-1 infection in adults to replace the current antiretroviral regimen in those who are virologically suppressed (HIV-1 RNA

Read full article on Medicalxpress

AI summaries can be wrong sometimes—always verify important details using the source article.